20B Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BioMark Diagnostics Inc

Watchlist Manager

Watchlist

Price: 0.28 EUR -2.1%

Market Cap: €25.4m

	BioMark Diagnostics Inc F:20B	CA
B	Beijing Media Corp Ltd F:BME	CN
	S2Medical AB (publ) F:S21	SE
T	Tosoh Corp XMUN:TOS	JP
I	iClick Interactive Asia Group Ltd F:I9CA	HK
S	S Immo AG XMUN:T1L	AT
C	China Yuchai International Ltd XMUN:CYD	SG

Profitability Summary

BioMark Diagnostics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2.304%

Negative 3Y Average Operating Margin

-1.319%

Declining Operating Margin

-1.239% > -2.304%

Negative Net Margin

-1.852%

Negative 3Y Average Net Margin

-1.181%

Declining Net Margin

-1.170% > -1.852%

Negative Free Cash Flow Margin

-2.233%

Negative 3Y Average Free Cash Flow Margin

-830%

Declining Free Cash Flow Margin

-534% > -2.233%

Exceptional ROE

576%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-405%

Declining ROIC

-327% > -451%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.